Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

123.38
Delayed Data
As of Mar 24
 +0.16 / +0.13%
Today’s Change
94.42
Today|||52-Week Range
127.64
+6.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line1.4B2.0B1.6B2.0B
 
 
 
 
 
Depreciation374.1M373.6M408.9M504.7M
 
 
 
 
 
Total Other Cash Flow644.2M590.2M556.6M1.3B
 
 
 
 
 
Funds From Operations2.2B2.7B2.5B3.4B
 
 
 
 
 
Funds From/For Other Operating Expenses-4.3M-114.9M50.2M-545.5M
 
 
 
 
 
Net Cash Flow - Operating Activities2.2B2.8B2.5B4.0B
 
 
 
 
 
 
InvestingIncrease In Investments-4.0B-2.7B-2.2B-1.4B
 
 
 
 
 
Decrease In Investments3.6B2.2B3.9B647.4M
 
 
 
 
 
Capital Expenditures-119.7M-150.3M-286.3M-236.2M
 
 
 
 
 
Net Assets From Acquisitions 0.00-710.0M-7.7B0.00
 
 
 
Other Investing - Uses-1.1M0.00-7.4M-600.0K
 
 
 
 
Net Cash Flow Investing-528.6M-1.4B-6.3B-1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings234.1M-445.3M-101.7M0.00
 
 
 
 
Long Term Borrowings1.5B2.5B7.9B0.00
 
 
 
 
Long Term Debt Reduction-----513.9M0.00
 
 
Net Proceeds Stock Sale552.8M307.5M251.7M366.7M
 
 
 
 
 
Common Preferred Redeemed-2.8B-3.0B-3.3B-2.2B
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing169.4M250.6M300.5M188.8M
 
 
 
 
 
Other Uses - Financing225.0M25.7M8.6M41.1M
 
 
 
 
 
Net Cash Flow - Financing-553.7M-417.4M4.6B-1.6B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash400.0K-63.7M-50.7M-38.9M
 
 
 
 
 
 
Net Change In Cash1.1B950.9M809.4M1.3B